ArticleNeurology and therapy2025

Beyond Efficacy: Persistence, NEDA, and Therapeutic Decision-Making in First-Line Multiple Sclerosis Treatment.

Clara Helena López-Caneda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.